Quantum Biopharma (QNTM) Interest Expenses (2019 - 2026)
Quantum Biopharma (QNTM) posted Interest Expenses of $22854.0 for Q1 2026, up 131.46% sequentially from -$72637.0 in Q4 2025, and down 9.93% YoY from $25374.0 in Q1 2025.
Quantum Biopharma (QNTM) Interest Expenses (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Interest Expenses for 8 years, with the latest figure at $22854.0 in Q1 2026.
- Quarterly Interest Expenses fell 9.93% year-over-year to $22854.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158749.0 (up 245.28% YoY) and the FY2025 annual result came in at $158063.0, up 378.73% from the prior year.
- Interest Expenses improved to $22854.0 in Q1 2026 per QNTM's latest filing, from -$72637.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $116962.0 in Q2 2025 and troughed at -$72637.0 in Q4 2025.
- A 5-year average of $17142.2 and a median of $11392.5 in 2024 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2024 and 2025: Interest Expenses soared 2829.21% in 2024, then sank 3973.97% in 2025.
- Over 5 years, Interest Expenses stood at -$9381.0 in 2022, then surged by 132.91% to $3087.0 in 2023, then slumped by 39.26% to $1875.0 in 2024, then tumbled by 3973.97% to -$72637.0 in 2025, then soared by 131.46% to $22854.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $22854.0, -$72637.0, and $91570.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 84,532.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,854.00 |
| Mar 31, 2026 | 22,854.00 |
| Dec 31, 2025 | -72,637.00 |
| Dec 31, 2025 | -72,637.00 |
| Sep 30, 2025 | 91,570.00 |
| Sep 30, 2025 | 91,570.00 |
| Jun 30, 2025 | 116,962.00 |
| Jun 30, 2025 | 116,962.00 |
| Mar 31, 2025 | 25,374.00 |
| Mar 31, 2025 | 25,374.00 |
| Dec 31, 2024 | 1,875.00 |
| Dec 31, 2024 | 1,875.00 |
| Sep 30, 2024 | 10,371.00 |
| Sep 30, 2024 | 10,371.00 |
| Jun 30, 2024 | 8,357.00 |
| Jun 30, 2024 | 8,357.00 |
| Mar 31, 2024 | 12,414.00 |
| Mar 31, 2024 | 12,414.00 |
| Dec 31, 2023 | 3,087.00 |
| Dec 31, 2023 | 3,087.00 |